Clinical Trials Sponsored by Mikrobiomik Healthcare Company S.L.

Total 2 results

Mikrobiomik Healthcare Company S.L.

Completed

Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin

Recurrent Clostridium Difficile Infection | Primary Clostridium Difficile Infection

Spain
Maimónides Biomedical Research Institute of Córdoba
Mikrobiomik Healthcare Company S.L.

Recruiting

Clinical Trial to Demonstrate the Effectiveness of Fecal Microbiota Transplantation for Selective Intestinal Decolonization of Patients Colonized by Carbapenemase-producing Klebsiella Pneumoniae (KAPEDIS)

Carbapenemase-producing Enterobacteriaceae Infection

Spain

3

Subscribe